Psychiatric Drug Mix for Young On Shaky Grounds_ NYTimes
The lead story in The New York Times on Thanksgiving day (below) acknowledged several facts demonstrating that children are the victims of major medical malpractice:
-
-
Conflict of Interest | Corrupt Practices | Gov. Medical Malfeasance | Government Agencies | Pharma Corrupt Influence
Former State Pharmacist (Pennsylvania) Faces Criminal charges
Steven Fiorello, former Chief Pharmacist for the State of Pennsylvania, was arraigned on on Tuesday, November 21, 2006, on Felony and Misdemeanor charges related to his accepting money from drug companies whose drugs he put on the state Formulary.
-
Psychiatry operates within a pre-Copernican framework of science
Dr. E. Jane Costello, a professor of psychiatry and behavioral sciences at Duke University, acknowledges: “The system of diagnosis is still 200 to 300 years behind other branches of medicine.” Psychiatry also fails to be guided by an evidence-based positive benefit / risk assessment of its prescribed treatments.
-
Whistleblower: Confessions of Healthcare Hitman
The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press.
-
Big Pharma Cashing In Like Robber Barrons on Medicare Rx Drug Law_NYT
The New York Times reports: "For big drug companies, the new Medicare prescription benefit is proving to be a financial windfall larger than even the most optimistic Wall Street analysts had predicted."
-
Conflicts of Interest Hopkins Study: Researchers Don’t Want to Disclose $$
Two surveys confirm medical researchers' resistance to complying with conflict of interest disclosure requirements.
-
Scientific Fraud: Eric Poehlman / Richard Borison
Medical researchers who commit fraud and research misconduct are caught only when a person of conscience steps up to the plate and blows the whistle. There are no systemic, independent checks and balances to prevent research fraud or abuse of patients.
-
Risks: Drugs / Vaccines / Trials / Treatments
Risks: Drugs / Vaccines / Trials / Treatment Evidence of antidepressant harm Oct 14, 2005: Andrew Finkelstein Letter to Dr. Russell Katz, Director, Neuropharmacological Drug Products, FDA about FDA’s Failure to Warn about Neurontin-Suicides Aug 29: FDA Response to Utah Court Must Be Truthful Re: Zoloft / SSRI Suicidal Risks…
-
Follow the Money / Can the Institute of Medicine Review the FDA?
Follow the Money / Can the Institute of Medicine Review the FDA? Wed, 6 Apr 2005 A letter to the editor published in Nature Medicine by Dr. Bernard Carroll, a past chairman of the FDA Advisory Committee for Psychotropic Drugs, and past chairman of the Department of Psychiatry at Duke…
-
Forbes: Judgment Day for the FDA, Pfizer
Forbes: Judgment Day for the FDA, Pfizer Wed, 9 Feb 2005 On Feb. 16-18 COX-2 Inhibitor Safety Issues will be the focus of an FDA Advisory Committee and (simultaneously) the European Medicines Agency (EMA). The entire drug industry will be watching with bated breath. Which causal explanation will be offered…
-
Documents Suggest Merck Tried to Censor Vioxx Critics – NPR
http://www.npr.org/templates/story/story.php?storyId=4696609 Documents Suggest Merck Tried to Censor Vioxx Critics NATIONAL PUBLIC RADIO All Things Considered, June 9, 2005 – Because of intense interest in this report, NPR has decided to present a full transcript. Introduction: At least 38,000 Americans are believed to have died from taking the pain pill Vioxx…
-
Lies & Broken Promises – Drug firm Websites Fail to Disclose Test Data
Lies & Broken Promises_Drug firm Websites Fail to Disclose Test Data Sun, 9 Jan 2005 One year after PhRMA’s publicized proclamation of its “commitment to transparency” The Boston Globe reviewed pharmaceutical company websites searching for disclosure of clinical trial data. The Globe found that this voluntary approach failed miserably: “Last…